pharma · Chronic Spontaneous Urticaria · Asthma
Novartis India
Novartis Pharmaceuticals
Novartis India clinical programs — 28 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Founded
- 1996
- Employees
- 2,240
- Programs
- 341
- Drugs
- 317
- Patents
- 0
Novartis India projects
28 ClinicalTrials.gov programs sponsored by Novartis India.
Novartis India has 28 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Aliskiren
Novartis Pharmaceuticals
Hypertension
1 trial -
CAIN457I2401
Novartis Pharmaceuticals
non-radiographic axial spondyloarthritis
1 trial -
CDRB436G2401
Novartis Pharmaceuticals
Children and Adolescents with Cancers Harboring V600 mutation.
1 trial -
CDRB436X2X02B
Novartis Pharmaceuticals
Multiple indications
1 trial -
CELC200A2406
Novartis Pharmaceuticals
Parkinson's Disease
1 trial -
CERITINIB
Novartis Pharmaceuticals
non small cell lung cancer
1 trial -
CINC424A2X01B
Novartis Pharmaceuticals
This study is designed to accept patients with varied disease origins, depending on the parent protocol
1 trial -
CKJX839A12402
Novartis Pharmaceuticals
Hypercholesterolemia
1 trial -
CKJX839A1DE02
Novartis Pharmaceuticals
Hypercholesterolemia
1 trial -
CLEE011A2412B
Novartis Pharmaceuticals
HR+, HER2- advanced or metastatic breast cancer
1 trial -
CLNP023A2002B
Novartis Pharmaceuticals
IgA Nephropathy
1 trial -
Enteric-Coated Mycophenolate Sodium (EC-MPS)
Novartis Pharmaceuticals
Renal Transplant
1 trial -
Fluvirin(TIVf)
Novartis Pharmaceuticals
Influenza
1 trial -
IPTACOPAN HYDROCHLORIDE, IPTACOPAN
Novartis Pharmaceuticals
C3 Glomerulopathy or idiopathic immune-complex membranoproliferative glomerulonephritis
1 trial -
Indacaterol
Novartis Pharmaceuticals
Chronic Obstructive Pulmonary Disease
1 trial -
Kesimpta 20 mg solution for injection in pre-filled syringe
Novartis Pharmaceuticals
Relapsing forms of Multiple Sclerosis (RMS)
1 trial -
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals
Neovacular Age-related Macular Degeneration
1 trial -
Ofatumumab
Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
1 trial -
Placebo of vildagliptin
Novartis Pharmaceuticals
Type 2 Diabetes Mellitus
1 trial -
Pluvicto 1 000 MBq/mL solution for injection/infusion
Novartis Pharmaceuticals
Prostate cancer
1 trial -
Ribociclib
Novartis Pharmaceuticals
Metastatic Breast Cancer
1 trial -
Rivastigmine
Novartis Pharmaceuticals
Alzheimer's Disease
1 trial -
Rivastigmine transdermal patch
Novartis Pharmaceuticals
Alzheimer's Disease
1 trial -
SEG101
Novartis Pharmaceuticals
Sickle cell disease
1 trial -
Secukinumab s.c. injection
Novartis Pharmaceuticals
Autoimmunity, Inflammation
1 trial -
Zoledronic Acid
Novartis Pharmaceuticals
Paget's Disease of the Bone
1 trial -
brinzolamide 1%/brimonidine 0.2% fixed combination
Novartis Pharmaceuticals
Glaucoma
1 trial -
dabrafenib
Novartis Pharmaceuticals
Melanoma
1 trial
Frequently asked questions
How many clinical projects does Novartis India have?
28 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.